Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

106.86
Delayed Data
As of Jul 29
 +1.02 / +0.96%
Today’s Change
41.99
Today|||52-Week Range
107.71
+100.83%
Year-to-Date

Today’s Trading

Previous close105.84
Today’s open106.48
Day’s range102.02 - 107.40
Volume280,746
Average volume (3 months)397,030
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 07/29/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+87.83%
Earnings growth (next 5 years)+46.08%
Revenue growth (last year)+31.78%
P/E ratio213.0
Price/Sales17.67
Price/Book78.72

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+0.96+1.72%
SAGESAGE Therapeutics In...-3.89-5.34%
LCILannett Company Inc+0.99+1.71%
ALDRAlder Biopharmaceuti...-1.94-4.05%
Data as of 4:01pm ET, 07/29/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.82
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts